# OnCo record mathematical-oncology (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/mathematical-oncology/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "mathematical-oncology" ;
  schema:name "Mathematical models of cancer (mathematical oncology)"@en ;
  schema:alternateName "mathematical models"@en, "mathematical model"@en, "mathematical oncology"@en, "biophysical models"@en, "computational models of cancer"@en, "tumour modelling"@en, "in silico oncology"@en, "cancer modelling"@en ;
  schema:description "Mathematical oncology writes down how tumours grow, evolve, respond to treatment and interact with the immune system as equations or simulations, then uses them to design doses, schedules and trials. The models themselves are records, each with what it was fitted to and what it was used to decide."@en ;
  schema:url <https://onco.cc/technologies/mathematical-oncology/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://en.wikipedia.org/wiki/Mathematical_oncology>, <https://onco.cc/models/>, <https://www.smb.org/mathematical-oncology/> ;
  onco:status "established" ;
  onco:tag "mathematical-model" ;
  onco:related <https://onco.cc/technologies/gompertzian-growth-model/>, <https://onco.cc/technologies/log-kill-hypothesis/>, <https://onco.cc/technologies/norton-simon-hypothesis/>, <https://onco.cc/technologies/goldie-coldman-model/>, <https://onco.cc/technologies/drug-resistance-dynamics/>, <https://onco.cc/technologies/adaptive-therapy-dynamics/>, <https://onco.cc/technologies/evolutionary-game-theory-cancer/>, <https://onco.cc/technologies/clonal-evolution-models/>, <https://onco.cc/technologies/reaction-diffusion-glioma-model/>, <https://onco.cc/technologies/agent-based-tumour-models/>, <https://onco.cc/technologies/immune-tumour-dynamics-models/>, <https://onco.cc/technologies/quantitative-systems-pharmacology/>, <https://onco.cc/technologies/pkpd-modelling/>, <https://onco.cc/technologies/body-surface-area-dosing/>, <https://onco.cc/technologies/tumour-control-probability-models/>, <https://onco.cc/technologies/fractionation-repopulation-models/>, <https://onco.cc/technologies/tumour-doubling-time/>, <https://onco.cc/technologies/angiogenesis-models/>, <https://onco.cc/technologies/tumour-mechanics-models/>, <https://onco.cc/technologies/metastasis-seeding-models/>, <https://onco.cc/technologies/mrd-kinetics-models/>, <https://onco.cc/technologies/digital-twin-patient-models/> ;
  onco:sections <https://onco.cc/fronts/ai-computation/>, <https://onco.cc/fronts/drug-discovery/> .